RSV and norovirus are making the rounds in the aftermath of holiday gatherings. Just in time to get back in the swing of work ...
Cocrystal Pharma has announced its intent to extend enrolment for its Phase IIa human challenge trial of CC-42344 ...
DAS-181 is under clinical development by Ansun Biopharma and currently in Phase III for Coronavirus Disease 2019 (COVID-19).
Coronavirus Disease 2019 (COVID-19) + influenza vaccine is under clinical development by Pfizer and currently in Phase II for Influenzavirus A Infections.